Healthcare provider profile · identity verified

Nancy Guttman, MD

Family Practice · MAYSVILLE, KY · NPI 1477551596

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	519	133
Gabapentin	Gabapentin	347	47
Levothyroxine Sodium	Levothyroxine Sodium	267	71
Metformin Hcl	Metformin Hcl	256	72
Lisinopril	Lisinopril	192	59
Amlodipine Besylate	Amlodipine Besylate	176	49
Pantoprazole Sodium	Pantoprazole Sodium	163	44
Omeprazole	Omeprazole	158	44
Losartan Potassium	Losartan Potassium	153	44
Jardiance	Empagliflozin	137	34
Metoprolol Succinate	Metoprolol Succinate	131	40
Albuterol Sulfate Hfa	Albuterol Sulfate	128	45
Sertraline Hcl	Sertraline Hcl	125	30
Alprazolam	Alprazolam	119	17
Alendronate Sodium	Alendronate Sodium	112	26
Pregabalin	Pregabalin	91	19
Duloxetine Hcl	Duloxetine Hcl	90	20
Pravastatin Sodium	Pravastatin Sodium	87	28
Hydrochlorothiazide	Hydrochlorothiazide	85	26
Fluticasone Propionate	Fluticasone Propionate	81	37
Montelukast Sodium	Montelukast Sodium	78	17
Clopidogrel	Clopidogrel Bisulfate	75	18
Olmesartan Medoxomil	Olmesartan Medoxomil	72	20
Famotidine	Famotidine	70	23
Rosuvastatin Calcium	Rosuvastatin Calcium	70	21
Tizanidine Hcl	Tizanidine Hcl	70	13
Ozempic	Semaglutide	68	11
Buspirone Hcl	Buspirone Hcl	67	22
Trulicity	Dulaglutide	67	suppressed
Ezetimibe	Ezetimibe	66	20
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	65	11
Citalopram Hbr	Citalopram Hydrobromide	64	16
Ropinirole Hcl	Ropinirole Hcl	63	15
Lorazepam	Lorazepam	62	suppressed
Furosemide	Furosemide	61	24
Hydroxyzine Hcl	Hydroxyzine Hcl	61	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	60	13
Amitriptyline Hcl	Amitriptyline Hcl	57	12
Tramadol Hcl	Tramadol Hcl	57	12
Potassium Chloride	Potassium Chloride	53	20
Januvia	Sitagliptin Phosphate	50	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	49	11
Clonazepam	Clonazepam	48	suppressed
Nebivolol Hcl	Nebivolol Hcl	46	11
Farxiga	Dapagliflozin Propanediol	44	12
Metoprolol Tartrate	Metoprolol Tartrate	42	11
Trazodone Hcl	Trazodone Hcl	42	12
Prednisone	Prednisone	40	33
Allopurinol	Allopurinol	39	suppressed
Meloxicam	Meloxicam	39	16
Lovastatin	Lovastatin	38	suppressed
Diclofenac Sodium	Diclofenac Sodium	37	14
Venlafaxine Hcl Er	Venlafaxine Hcl	37	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	36	12
Carvedilol	Carvedilol	35	13
Ondansetron Odt	Ondansetron	34	12
Spironolactone	Spironolactone	34	suppressed
Synthroid	Levothyroxine Sodium	33	11
Methocarbamol	Methocarbamol	32	suppressed
Simvastatin	Simvastatin	31	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	30	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	30	11
Doxepin Hcl	Doxepin Hcl	29	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	29	suppressed
Topiramate	Topiramate	29	11
Myrbetriq	Mirabegron	28	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	28	18
Zolpidem Tartrate	Zolpidem Tartrate	28	suppressed
Azithromycin	Azithromycin	25	22
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	25	suppressed
Ibuprofen	Ibuprofen	25	suppressed
Mirtazapine	Mirtazapine	25	suppressed
Ventolin Hfa	Albuterol Sulfate	25	12
Bupropion Xl	Bupropion Hcl	24	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	23	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	22	suppressed
Enalapril Maleate	Enalapril Maleate	22	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	22	suppressed
Vascepa	Icosapent Ethyl	22	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	21	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	21	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	21	suppressed
Nitroglycerin	Nitroglycerin	20	12
Raloxifene Hcl	Raloxifene Hcl	20	suppressed
Tresiba Flextouch U-200	Insulin Degludec	20	suppressed
Atenolol	Atenolol	19	suppressed
Celecoxib	Celecoxib	18	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	18	suppressed
Ketoconazole	Ketoconazole	18	11
Naproxen	Naproxen	18	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	18	14
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	17	suppressed
Easy Comfort Pen Needle	Pen Needle, Diabetic	17	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	17	suppressed
Cefdinir	Cefdinir	16	13
Benazepril Hcl	Benazepril Hcl	15	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	15	suppressed
Testosterone	Testosterone	15	suppressed
Diazepam	Diazepam	14	suppressed
Linzess	Linaclotide	14	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	14	suppressed
Breo Ellipta	Fluticasone/Vilanterol	13	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	13	suppressed
Donepezil Hcl	Donepezil Hcl	13	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	13	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	13	suppressed
Varenicline Tartrate	Varenicline Tartrate	13	suppressed
Vraylar	Cariprazine Hcl	13	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	12	suppressed
Carbamazepine	Carbamazepine	12	suppressed
Clobetasol Propionate	Clobetasol Propionate	12	suppressed
Ibandronate Sodium	Ibandronate Sodium	12	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	12	suppressed
Metformin Hcl Er	Metformin Hcl	12	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	12	suppressed
Techlite Pen Needle	Pen Needle, Diabetic	12	suppressed
Xarelto	Rivaroxaban	12	suppressed
Ammonium Lactate	Ammonium Lactate	11	suppressed
Cephalexin	Cephalexin	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Nystatin	Nystatin	11	suppressed
Prolia	Denosumab	11	suppressed
Santyl	Collagenase Clostridium Hist.	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error